Skip to main content
    • Aa
    • Aa

Emerging roles of pathogens in Alzheimer disease

  • Judith Miklossy (a1)

Chronic spirochetal infection can cause slowly progressive dementia, cortical atrophy and amyloid deposition in the atrophic form of general paresis. There is a significant association between Alzheimer disease (AD) and various types of spirochete (including the periodontal pathogen Treponemas and Borrelia burgdorferi), and other pathogens such as Chlamydophyla pneumoniae and herpes simplex virus type-1 (HSV-1). Exposure of mammalian neuronal and glial cells and organotypic cultures to spirochetes reproduces the biological and pathological hallmarks of AD. Senile-plaque-like beta amyloid (Aβ) deposits are also observed in mice following inhalation of C. pneumoniae in vivo, and Aβ accumulation and phosphorylation of tau is induced in neurons by HSV-1 in vitro and in vivo. Specific bacterial ligands, and bacterial and viral DNA and RNA all increase the expression of proinflammatory molecules, which activates the innate and adaptive immune systems. Evasion of pathogens from destruction by the host immune reactions leads to persistent infection, chronic inflammation, neuronal destruction and Aβ deposition. Aβ has been shown to be a pore-forming antimicrobial peptide, indicating that Aβ accumulation might be a response to infection. Global attention and action is needed to support this emerging field of research because dementia might be prevented by combined antibiotic, antiviral and anti-inflammatory therapy.

Corresponding author
*Corresponding author: Judith Miklossy, 1921 Martigny-Croix CP 16, 1921, Switzerland. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2 A. Alzheimer (1911) Über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte Neurologie und Psychiatrie 4, 356385

3 R. Katzman (1976) The prevalence and malignancy of Alzheimer's disease: a major killer. Archives of Neurology 33, 217218

4 R.D. Terry and P. Davies (1980) Dementia of the Alzheimer type. Annual Review of Neuroscience 3, 7795

9 R.D. Terry (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 30, 572580

10 J. Kang (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733736

11 D.J. Selkoe (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biology 8, 447453

12 G.G. Glenner and C.W. Wong (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications 120, 885890

13 D. Schubert (1988) Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Science 241, 17591763

14 A.I. Bush , K. Beyreuther and C.L. Masters (1993) The beta A4 amyloid protein precursor in human circulation. Annals of the New York Academy of Sciences 695, 175182

16 J.S. Allen (1991) Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neuroscience Letters 132, 109112

17 U. Mönning (1990) Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Letters 277, 261266

19 J.T. Jarrett and P.T. Lansbury (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31, 1234512352

20 W. Kim and M.H. Hecht (2005) Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40. Journal of Biological Chemistry 280, 3506935076

21 M.P. Lambert (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America 95, 64486453

23 D.M. Walsh (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535539

24 M.D. Kirkitadze , G. Bitan and D.B. Teplow (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. Journal of Neuroscience Research 69, 567577

25 E. Cerf (2009) Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta- peptide. Biochemical Journal 421, 415423

26 J. Pitt (2009) Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicology and Applied Pharmacology 240, 189197

27 H.A. Lashuel (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291

28 T. Rudel (1996) Modulation of Neisseria porin (PorB) by cytosolic ATP/GTP of target cells: parallels between pathogen accommodation and mitochondrial endosymbiosis. Cell 85, 391402

29 P. Ayala (2005) The pilus and porin of Neisseria gonorrhoeae cooperatively induce Ca(2+) transients in infected epithelial cells. Cellular Microbiology 7, 17361748

30 A. Müller (1999) Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO Journal 18, 339352

31 S.J. Soscia (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505

32 M. Kidd (1963) Paired helical filaments in electron microscopy of Akzheimer's disease. Nature 197, 192193

33 R.D. Terry (1963) The fine structure of neurofibrillary tangles in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 22, 629642

35 V.M.-Y. Lee (1995) Disruption of the cytoskeleton in Alzheimer's disease. Current Opinion in Neurobiology 5, 663668

36 P.J. Lu (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784788

37 R. Sherrington (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754760

38 D.J. Selkoe (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. Journal of Biological Chemistry 271, 1829518298

39 J. Hardy (1997) The Alzheimer family of diseases: many etiologies, one pathogenesis? Proceedings of the National Academy of Sciences of the United States of America 94, 20952097

40 R.E. Tanzi and L. Bertram (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181184

41 J. Hardy and D.J. Selkoe (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353356

42 L. Bertram and R.E. Tanzi (2005) The genetic epidemiology of neurodegenerative disease. Journal of Clinical Investigation 115, 14491457

43 Z. Nagy (2005) The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. Journal of Cellular and Molecular Medicine 9, 531541

44 G.D. Schellenberg (1995) Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proceedings of the National Academy of Sciences of the United States of America 92, 85528559

45 A. Goate (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704706

46 M. Mullan (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics 1, 345347

48 W. Wasco (1995) Familial Alzheimer's chromosome 14 mutations. Nature Medicine 1, 848

49 J. Perez-Tur (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297301

50 J. Miklossy (2003) Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-on set Alzheimer's disease. Neurobiology of Aging 24, 655662

51 E. Levy-Lahad (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973977

52 M. Citron (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672674

53 X.D. Cai , T.E. Golde and S.G. Younkin (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259, 514516

54 N. Suzuki (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 13361340

55 K. Duff (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710713

56 D. Scheuner (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine 2, 864870

57 D.R. Borchelt (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 10051013

58 T. Tomita (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proceedings of the National Academy of Sciences of the United States of America 94, 20252030

59 M. Citron (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine 3, 6772

61 P.L. McGeer and E.G. McGeer (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Archives of Neurology 58, 17901792

62 L. Bertram (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 39, 1723

63 J. Guo (2006) A-beta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 103, 19531958

65 P. Davies , R. Katzman and R.D. Terry (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288, 279280

66 E.K. Perry (1981) Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiology of Aging 2, 251256

70 R.T. Bartus (1985) The cholinergic hypothesis: a historical overview, current perspective, and future directions. Annals of the New York Academy of Sciences 444, 332358

71 R.N. Martins (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. Journal of Neurochemistry 46, 10421045

72 M.A. Pappolla (1996) The heat shock/oxidative stress connection. Relevance to Alzheimer disease. Molecular and Chemical Neuropathology 28, 2134

73 M.A. Smith (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Annals of the New York Academy of Sciences 738, 447454

74 A. Nunomura (2006) Involvement of oxidative stress in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 65, 631641

75 W.D. Parker Jr. (1991) Cytochrome oxidase deficiency in Alzheimer's disease. Annals of the New York Academy of Sciences 640, 5964

76 R.D. Terry and C. Pena (1965) Experimental production of neurofibrillary degeneration: electron microscopy, phosphatase histochemistry and electron probe analysis. Journal of Neuropathology and Experimental Neurology 24, 200210

77 D.R. Crapper , S.S. Krishnan and A.J. Dalton (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180, 511513

78 K. Jellinger (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 2, 327340

79 Y.H. Suh (1996) Molecular physiology, biochemistry, and pharmacology of Alzheimer's amyloid precursor protein (APP). Annals of the New York Academy of Sciences 786, 169183

80 Z.S. Khachaturian (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Annals of the New York Academy of Sciences 747, 111

81 H. Mori , J. Kondo and Y. Ihara (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 16411644

82 Y.A. Lam (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 97, 99029906

83 J.C. de la Torre and T. Mussivand (1993) Can disturbed brain microcirculation cause Alzheimer's disease? Neurological Research 15, 146153

84 M.M. Esiri (1999) Cerebrovascular disease and threshold for dementia in the early stage of Alzheimer's disease. Lancet 354, 919920

85 V. Hachinski and D.G. Munoz (1997) Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon? Annals of the New York Academy of Sciences 826, 16

86 D.A. Snowdon (1997) Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. Journal of the American Medical Association 277, 813817

87 G.I. De Jong (1997) Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies. Annals of the New York Academy of Sciences 826, 5674

88 J.F. Diaz (1991) Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Archives of Neurology 48, 10221025

89 R.N. Kalaria (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging 21, 321330

90 O.C. Suter (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33, 19861992

91 J. Miklossy (2003) Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurological Research 25, 605610

93 D.L. Sparks (1997) Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Annals of the New York Academy of Sciences 826, 128146

95 D.M. Mann , C.M. Tucker and P.O. Yates (1988) Alzheimer's disease: an olfactory connection? Mechanisms of Aging and Development 42, 115

96 J.A. Hardy (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiology of Aging 7, 489502

98 P.L. McGeer (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neuroscience Letters 79, 195200

99 W.S. Griffin (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 86, 76117615

100 P.L. McGeer and J. Rogers (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42, 447449

102 P.L. McGeer and E.G. McGeer (1995) The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Reviews 21, 195218

103 P.L. McGeer and E.G. McGeer (2002) Local neuroinflammation and the progression of Alzheimer's disease. Journal of Neurovirology 8, 529538

104 S. Webster (1997) Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiology of Aging 18, 415421

105 W.F. Stewart (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626632

106 P.P. Zandi (2000) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59, 880886

108 H. Akiyama (2000) Inflammation and Alzheimer's disease. Neurobiology of Aging 21, 383421

109 O. Fischer (1907) Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschrift für Psychiatrie und Neurologie 22, 361372

111 Z.S. Khachaturian (1985) Diagnosis of Alzheimer's disease. Archives of Neurology 42, 10971105

112 A.H. Hübner (1908) Zur Histopathologie der senilen Hirnrinde. Archives of Psychiatry and Neurology 46, 598609

118 J. Miklossy (2008) Biology and neuropathology of dementia in syphilis and Lyme disease. In Dementias, Handbook of Clinical Neurology ( C. Duyckaerts and I. Litvan , eds), Vol. 89, pp. 825844, Elsevier, Edinburgh, London

119 H. Noguchi and J.W. Moore (1913) A demonstration of Treponema pallidum in the brain of general paralysis cases. Journal of Experimental Medicine 17, 232238

127 P. Saikku (1999) Epidemiology of Chlamydia pneumoniae in atherosclerosis. American Heart Journal 138 (Suppl), 500503

128 M.A. Mendall (1994) Relation of Helicobacter pylori infection and coronary heart disease. British Heart Journal 71, 437439

129 C. Martin de Argila (1995) High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet 346, 310

130 S. Renvert (2006) Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. Journal of Periodontology 77, 11101119

131 M. Zaremba (2007) Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels. Journal of Periodontology 78, 322327

132 B. Chiu (1999) Multiple infections in carotid atherosclerotic plaques. American Heart Journal 138, S534S536

133 V.I. Haraszthy (2000) Identification of periodontal pathogens in atheromatous plaques. Journal of Periodontology 71, 15541560

134 M. Rassu (2001) Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 158, 7379

135 R.J. Martin (2006) Infections and asthma. Clinics in Chest Medicine 27, 8798

136 A.L. MacDowell and L.B. Bacharier (2005) Infectious triggers of asthma. Immunology and Allergy Clinics of North America 25, 4566

138 R.J. Marttila (1977) Viral antibodies in the sera from patients with Parkinson disease. European Neurology 15, 2533

139 R. Rott (1985) Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755756

142 M. Salvatore (1997) Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet 349, 18131814

143 D. Langford and E. Masliah (2003) The emerging role of infectious pathogens in neurodegenerative diseases. Experimental Neurology 184, 553555

144 B.J. Balin (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Medical Microbiology and Immunology 187, 2342

146 J. Miklossy (1993) Alzheimer's disease – a spirochetosis? Neuroreport 4, 841848

147 G.R. Riviere , K.H. Riviere and K.S. Smith (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiology and Immunology 17, 113118

150 G.A. Jamieson (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. Journal of Medical Virology 33, 224227

152 J.M. Olichney (2000) Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Archives of Neurology 57, 869874

153 J.A. Luchsinger (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545551

154 T. Voisin (2003) Vascular risk factors and Alzheimer's disease. La Revue de Medecine Interne 24 (Suppl), 288291

155 A. Ott (1996) Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39, 13921397

157 B.L. Pihlstrom , B.S. Michalowicz and N.W. Johnson (2005) Periodontal diseases. Lancet 366, 18091820

158 F.C. Gibson III (2004) Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 28012806

159 K.J. Mattila , P.J. Pussinen and S. Paju (2005) Dental infections and cardiovascular diseases: a review. Journal of Periodontology 76 (Suppl), 20852088

160 B. Seppaa and J. Ainamo (1996) Dark field microscopy of the subgingival microflora in insulin-dependent diabetics. Journal of Clinical Periodontology 23, 6367

161 L.J. Ling (2004) Association between human herpesviruses and the severity of periodontitis. Journal of Periodontology 75, 14791485

163 N.M. O'Brien-Simpson (2004) Antigens of bacteria associated with periodontitis. Periodontology 2000 35, 101134

164 T.J. DeGraba (2004) Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation. Stroke 35 (Suppl 1), 27122719

165 H. Kolb and T. Mandrup-Poulsen (2005) An immune origin of type 2 diabetes? Diabetologia 48, 10381050

166 F.E. Dewhirst (2000) The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiology and Immunology 15, 196202

169 A.S. Mikosza (2001) Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia. Journal of Clinical Microbiology 39, 347350

170 W. Burgdorfer (1982) Lyme disease-a tick-borne spirochetosis? Science 216, 13171319

171 E.C. Chan (1996) Characterization of a 4.2-kb plasmid isolated from periodontopathic spirochetes. Oral Microbiology and Immunology 11, 365368

173 S. Peters (1999) Adherence to and penetration through cells by oral treponemes. Oral Microbiology and Immunology 14, 379383

174 C. Wyss (2004) Treponema putidum sp. nov., a medium-sized proteolytic spirochaete isolated from lesions of human periodontitis and acute necrotizing ulcerative gingivitis. International Journal of Systematic and Evolutionary Microbiology 54, 11171122

175 J. Miklossy (2008) Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. Journal of Neuroinflammation 5, 40

178 A.B. MacDonald and J.M. Miranda (1987) Concurrent neocortical borreliosis and Alzheimer's disease. Human Pathology 18, 759761

179 L. Meer-Scherrer (2006) Lyme disease associated with Alzheimer's disease. Current Microbiology 52, 330332

180 M. Gutacker (1998) Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Research in Microbiology 149, 3135

181 A.R. Marques (2000) Lack of evidence of Borrelia involvement in Alzheimer's disease. Journal of Infectious Diseases 182, 10061007

182 A. Galbussera (2008) Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Disease and Associated Disorder 22, 308

183 A.B. MacDonald (2006) Transfection “Junk” DNA – a link to the pathogenesis of Alzheimer's disease? Medical Hypotheses 66, 11401141

184 A.B. MacDonald (2006) Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Medical Hypotheses. 67, 592600

185 M.A. Pappolla (1989) Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Human Pathology 20, 753757

186 J. Miklossy (1994) The spirochetal etiology of Alzheimer's disease: A putative therapeutic approach. In Alzheimer Disease: Therapeutic Strategies. Proceedings of the Third International Springfield Alzheimer Symposium ( E. Giacobini and R. Becker , eds), Part I, pp. 4148, Birkhauser, Boston

187 J. Miklossy (1994) Further morphological evidence for a spirochetal etiology of Alzheimer's Disease. NeuroReport 5, 12011204

190 L. Hesse (2003) Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. Journal of Bacteriology 185, 65076512

191 A.J. McCoy (2006) L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine. Proceedings of the National Academy of Sciences of the United States of America 103, 1790917914

192 R. McLaughlin (1999) Alzheimer's disease may not be a spirochetosis. Neuroreport 10, 14891491

194 A.B. MacDonald (1986) Borrelia in the brains of patients dying with dementia. Journal of the American Medical Association 256, 21952196

199 A.B. MacDonald (1988) Concurrent neocortical borreliosis and Alzheimer's Disease. Annals of the New York Academy of Sciences 539, 468470

200 H.C. Gérard (2005) The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microbial Pathogenesis 39, 1926

201 H.C. Gérard (2006) Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunology and Medical Microbiology 48, 355366

202 B. Paradowski (2007) Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. Journal of Neurology 254, 154159

203 D.M. Appelt (2008) Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neuroscience 9, 13

205 H.H. Kornhuber (1996) Propionibacterium acnes in the cortex of patients with Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience 246, 108109

207 A.P. Hudson (2000) Chlamydia pneumoniae, APOE genotype, and Alzheimer's disease. In Chlamydial Basis of Chronic Diseases ( L. Dolmer , ed.), pp. 121–36, Robert Koch Institute, Springer Verlag, New York

209 I. Brook (2008) Microbiology and management of joint and bone infections due to anaerobic bacteria. Journal of Orthopaedic Science 13, 160169

210 K. Honjo , R. van Reekum and N.P. Verhoeff (2009) Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimer's Dementia 5, 348360

211 A. MacIntyre (2003) Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. Journal of Neuroscience Research 71, 740750

212 N.M. Albert (2000) Inflammation and infection in acute coronary syndrome. Journal of Cardiovascular Nursing 15, 1326

214 U. Dreses-Werringloer (2006) Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. American Journal of the Medical Sciences 332, 168174

215 U. Dreses-Werringloer (2009) Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. International Journal of Medical Microbiology 299, 187201

216 D. Nochlin (1999) Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 53, 1888

218 D. Preza (2008) Bacterial profiles of root caries in elderly patients. Journal of Clinical Microbiology 46, 20152021

221 J. Howard and G.J. Pilkington (1992) Fibronectin staining detects micro-organisms in aged and Alzheimer's disease brain. Neuroreport 3, 615618

224 M. Malaguarnera (2004) Helicobacter pylori and Alzheimer's disease: a possible link. European Journal of Internal Medicine 15, 381386

225 J. Kountouras (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66, 938940

226 J. Kountouras (2009) Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. International Journal of Neuroscience 119, 765777

227 J. Kountouras (2007) Association between Helicobacter pylori infection and mild cognitive impairment. European Journal of Neurology 14, 976982

228 G.A. Jamieson (1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. Journal of Pathology 167, 365368

230 F. Xu (2006) Trends in Herpes simplex virus type 1 and type 2 seroprevalence in the United States. Journal of the American Medical Association 296, 964973

234 B.G. Pogo , J. Casals and T.S. Elizan (1987) A study of viral genomes and antigens in brains of patients with Alzheimer's disease. Brain 110, 907915

235 D.G. Walker , J.R. O'Kusky and P.L. McGeer (1989) In situ hybridization analysis for herpes simplex virus nucleic acids in Alzheimer disease. Alzheimer Disease and Associated Disorder 3, 123131

() . , –236 R.F. Itzhaki 1997 Herpes simplex virus type 1 in brain and risk of Alzheimer's disease Lancet 349 241244

237 S. Itabashi (1997) Herpes simplex virus and risk of Alzheimer's disease. Lancet 349, 1102

239 U. Beffert (1998) HSV-1 in brain and risk of Alzheimer's disease. Lancet 351, 13301331

241 M.A. Wozniak , A.P. Mee and R.F. Itzhaki (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. Journal of Pathology 217, 131138

242 M.A. Wozniak (2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. Journal of Medical Virology 75, 300306

243 E.B. Renvoize , I.O. Awad and M.H. Hambling (1987) A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age and Ageing 16, 311314

244 A. Ounanian (1990) Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease. Journal of Clinical Laboratory Analysis 4, 367375

245 L. Letenneur (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 3, 3637

246 W.R. Lin (2002) Herpesviruses in brain and Alzheimer's disease. Journal of Pathology 197, 395402

248 A. Aiello (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 54, 10461054

249 T. Matsuse (1994) Immunohistochemical and in situ hybridisation detection of adenovirus early region 1A (E1A) gene in the microglia of human brain tissue. Journal of Clinical Pathology 47, 275277

250 T. Igata (1997) Dementia and Borna disease virus. Dementia and Geriatric Cognitive Disorders 9, 2425

252 R.M. Chalmers , D.R. Thomas and R.L. Salmon (2005) Borna disease virus and the evidence for human pathogenicity: a systematic review. QJM 98, 255274

253 T. Stahl (2006) Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. European Journal of Neuroscience 24, 19231934

254 H.C. Rempel and L. Pulliam (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (London, England) 19, 127135

255 W. Lang (1989) Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathologica 77, 379390

256 E.W. Hook III (1989) Syphilis and HIV infection. Journal of Infectious Diseases 160, 530534

257 U.V. Comandini (1997) Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus. European Journal of Clinical Microbiology and Infectious Diseases 16, 720726

258 A.A. Tobian and T.C. Quinn (2009) Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Current Opinion in HIV and AIDS 4, 294299

259 J.S. Burgos (2006) Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. Journal of Virology 80, 53835387

260 R.M. Miller and H.J. Federoff (2008) Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiology of Aging 29, 7177

261 J. Miklossy (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiology of Aging 27, 228236

262 C.S. Little (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiology of Aging 25, 419429

264 D.H. Cribbs (2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's Aβ peptide. Biochemistry 39, 59885994

265 P. Satpute-Krishnan , J.A. DeGiorgis and E.L. Bearer (2003) Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease. Aging Cell 2, 305318

266 M.A. Wozniak (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neuroscience Letters 429, 95100

270 I. Boggian (2000) Asymptomatic herpes simplex type 1 virus infection of the mouse brain. Journal of Neurovirology 6, 303313

271 T. Valyi-Nagy (2000) Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278, 309321

272 A. Fox (1990) Role of bacterial debris in inflammatory diseases of the joint and eye. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 98, 957968

275 N. Palaniyar (2002) Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 205, 575594

276 M.F. Gebbink (2005) Amyloids–a functional coat for microorganisms. Nature Reviews. Microbiology 3, 333341

278 U. Gophna (2001) Curli fibers mediate internalization of Escherichia coli by eukaryotic cells. Infection and Immunity 69, 26592665

279 A. Ben Nasr (1996) Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Molecular Microbiology 20, 927935

280 A. Olsén , A. Jonsson and S. Normark (1989) Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 338, 652655

281 U. Sjöbring , G. Pohl and A. Olsén (1994) Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Molecular Microbiology 14, 443445

282 M. Hammar (1995) Expression of two csg operons is required for production of fibronectin- and congo red-binding curli polymers in Escherichia coli K-12. Molecular Microbiology 18, 661670

283 T. Umemoto , M. Li and I. Namikawa (1997) Adherence of human oral spirochetes by collagen-binding proteins. Microbiology and Immunology 41, 917923

284 P.J. Crack and P.J. Bray (2007) Toll-like receptors in the brain and their potential roles in neuropathology. Immunology and Cell Biology 85, 476480

285 E. Lorenz (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Archives of Internal Medicine 162, 10281032

286 S. Kiechl , C.J. Wiedermann and J. Willeit (2003) Toll-like receptor 4 and atherogenesis. Annals of Medicine 35, 164171

287 S. Akira and K. Takeda (2004) Functions of toll-like receptors: lessons from KO mice. Comptes Rendus Biologies 327, 581589

288 P. Tobias and L.K. Curtiss (2005) Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. Journal of Lipid Research 46, 404411

289 S.E. Turvey and T.R. Hawn (2006) Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clinical Immunology 120, 19

292 N.W. Schroeder (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. Journal of Immunology 173, 26832691

294 G. Ramesh (2003) Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. European Journal of Immunology 33, 25392550

297 F.G.E. Van der Goot (2001) Pore Forming Toxins. Springer Verlag, Berlin

298 N.O. Gekara (2007) The multiple mechanisms of Ca(2+) signalling by listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes. Cellular Microbiology 9, 20082021

299 M.R. Gonzalez (2008) Bacterial pore-forming toxins: The (w)hole story ? Cellular and Molecular Life Sciences 65, 493507

300 N.O. Gekara and S. Weiss (2004) Lipid rafts clustering and signalling by listeriolysin O. Biochemical Society Transactions 32, 712714

301 P. Cossart and M. Lecuit (1998) Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO Journal 17, 37973806

302 S. Kayal (1999) Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Molecular Microbiology 31, 17091722

303 M.A. Hamon (2007) Histone modifications induced by a family of bacterial toxins. Proceedings of the National Academy of Sciences of the United States of America 104, 1346713472

304 M.E. Pipkin and J. Lieberman (2007) Delivering the kiss of death: Progress on understanding how perforin works. Current Opinion in Immunology 19, 301308

306 M.B. Lawrenz (2003) Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infection and Immunity 71, 44324440

307 P. Kraiczy (2001) Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. International Immunopharmacology 1, 393401

308 L.C. Stanley (1994) Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 53, 231238

309 N.A. Brabers and H.S. Nottet (2006) Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. European Journal of Clinical Investigation 36, 447458

310 J.G. Sheng (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiology of Aging 17, 761766

311 D. Goldgaber (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 86, 76067610

312 S.W. Barger (2008) Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. Journal of Neuropathology and Experimental Neurology 67, 773783

314 J.G. Sheng (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Experimental Neurology 163, 388391

315 J.G. Sheng (2001) Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochemistry International 39, 341348

317 S.G. Zhu (1999) Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 58, 582587

318 Y. Li (2004) Microglial activation by uptake of fDNA via a scavenger receptor. Journal of Neuroimmunology 147, 5055

319 S.W. Barger and A.D. Harmon (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878881

320 K. Tahara (2006) Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129, 30063019

321 H. Scholtzova (2009) Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. Journal of Neuroscience 29, 18461854

322 P. Kraiczy and R. Würzner (2006) Complement escape of human pathogenic bacteria by acquisition of complement regulators. Molecular Immunology 43, 3144

323 M. Pausa (2003) Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Journal of Immunology 170, 32143222

324 A. Rasley , J. Anguita and I. Marriott (2002) Borrelia burgdorferi induces inflammatory mediator production by murine microglia. Journal of Neuroimmunology 130, 2231

325 B. Hauss-Wegrzyniak , P.D. Vraniak and G.L. Wenk (2000) LPS-induced neuroinflammatory effects do not recover with time. Neuroreport 11, 17591763

326 T.J. Lehman (1983) Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis and Rheumatism 26, 12591265

327 L. Johannsen (1993) Biological properties of bacterial peptidoglycan. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 101, 337344

329 L.N. Heiss (1994) Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proceedings of the National Academy of Sciences 91, 267270

331 E. Griffiths (1991) Iron and bacterial virulence - a brief overview. Biological Methods 4, 713

332 E.D. Weinberg (1992) Iron depletion: a defense against intracellular infection and neoplasia. Life Sciences 50, 12891297

333 W.J. Griffiths (2000) Localization of iron transport and regulatory proteins in human cells. QJM 93, 575587

334 L. Goodman (1953) Alzheimer's disease; a clinico-pathologic analysis of twenty- three cases with a theory on pathogenesis. Journal of Nervous and Mental Disease 118, 97130

335 G.M. Bishop (2002) Iron: a pathological mediator of Alzheimer disease? Developmental Neuroscience 24, 184187

336 L.M. Miller (2006) Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. Journal of Structural Biology 155, 3037

337 P. Lirk , G. Hoffmann and J. Rieder (2002) Inducible nitric oxide synthase – time for reappraisal. Curr Drug Targets – Inflammation and Allergy 1, 89108

338 E.D. Chan , J. Chan and N.W. Schluger (2001) What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. American Journal of Respiratory Cell and Molecular Biology 25, 606612

339 D. Chakravortty and M. Hensel (2003) Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes and Infection 5, 621627

340 M.U. Shiloh and C.F. Nathan (2000) Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Current Opinion in Microbiology 3, 3542

341 C. Bogdan (2001) Nitric oxide and the immune response. Nature Immunology 2, 907916

342 S. Ohnishi , A. Koide and S. Koide (2001) The roles of turn formation and cross- strand interactions in fibrillization of peptides derived from the OspA single-layer beta-sheet. Protein Science 10, 20832092

343 D. Otzen and P.H. Nielsen (2008) We find them here, we find them there: functional bacterial amyloid. Cellular and Molecular Life Sciences 65, 910927

344 M.R. Chapman (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851855

345 P. Larsen (2007) Amyloid adhesins are abundant in natural biofilms. Environmental Microbiology 9, 30773090

346 P.B. Jordal (2009) Widespread abundance of functional bacterial amyloid in Mycolata and other Gram-positive bacteria. Applied and Environmental Microbiology 75, 41014110

347 X. Wang , N.D. Hammer and M.R. Chapman (2008) The molecular basis of functional bacterial amyloid polymerization and nucleation. Journal of Biological Chemistry 283, 2153021539

349 B. Hauss-Wegrzyniak and G.L. Wenk (2002) Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neuroscience Letters 322, 7578

350 J. Miklossy (2010) Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging. 31:15031515

351 M. Kitazawa (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. Journal of Neuroscience 25, 88438853

352 J.C. Knight and D. Kwiatkowski (1999) Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proceedings of the Association of American Physicians 111, 290298

353 M.A. Shaw (2001) Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes and Immunity 2, 196204

354 S. Roy (1997) Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. Journal of Infectious Diseases 176, 530532

355 A. Marangoni (2004) Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunology and Medical Microbiology 40, 187191

356 A.C. Steere , E. Dwyer and R. Winchester (1990) Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. New England Journal of Medicine 323, 21923

358 J.S. Collins (2000) Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. American Journal of Medical Genetics 96, 823830

359 S.M. McCusker (2001) Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 357, 436439

360 A. Gnjec (2008) Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. Journal of Neuroinflammation 5, 36

362 C. Ballerini (1999) HLA A2 allele is associated with age at onset of Alzheimer's disease. Annals of Neurology 45, 397400

363 W.S. Griffin (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. Journal of Neuropathology and Experimental Neurology 54, 276281

364 J.A. Nicoll (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Annals of Neurology 47, 365368

365 P. Minoretti (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neuroscience Letters 391, 147149

366 C.R. Balistreri (2008) Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Current Pharmaceutical Design 14, 26722677

368 F. Licastro (2007) Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiology of Aging 28, 16371643

369 E.H. Corder (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature Medicine 4, 11821184

370 R.F. Itzhaki (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiology of Aging 25, 619627

371 R.F. Itzhaki and M.A. Wozniak (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Progress in Lipid Research 45, 7390

372 P.S. Bhattacharjee (2008) Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Experimental Eye Research 87, 122130

373 R.F. Itzhaki and M.A. Wozniak (2010) Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimer's Dementia 6, 8384

374 V.H. Perry , C. Cunningham and C. Holmes (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nature Reviews. Immunology 7, 161167

375 V.H. Perry , J.A. Nicoll and C. Holmes (2010) Microglia in neurodegenerative disease. Nature Reviews. Neurology 6, 193201

376 C. Holmes and D. Cotterell (2009) Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 23, 9931002

377 A.R. Kamer (2009) TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. Journal of Neuroimmunology 216, 9297

378 R. Blatz (2005) Neurosyphilis and neuroborreliosis. Retrospective evaluation of 22 cases. Der Nervenarzt 76, 724732

379 D. Bolintineanu (2009) Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides 31, 18

380 N. Kobayashi (2008) Binding sites on tau proteins as components for antimicrobial peptides. Biocontrol Science 13, 4956

381 S.S. Shaftel (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. Journal of Clinical Investigation 117, 15951604

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 28
Total number of PDF views: 115 *
Loading metrics...

Abstract views

Total abstract views: 709 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st September 2017. This data will be updated every 24 hours.